This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.

Adverse event reporting can be found at the bottom of the page.

Sanofi branded clouded background image

Type 2 Diabetes

Latest Education

Education14 Oct 2024

Paradigm 2024: Lesley Mills

Recording from Paradigm 2024

Education14 Oct 2024

Paradigm 2024: Anne Goodchild

Recording from Paradigm 2024

Education14 Oct 2024

Paradigm 2024: Ketan Dhatariya

Recording from Paradigm 2024

Education14 Oct 2024

Paradigm 2024: Saqib Mahmud

Recording from Paradigm 2024

Sohail Akhtar - 29.03.24

Education17 Apr 2024

Diabetes UK 2024: Sustainably scripting tomorrow with Sanofi's Planet Cares Programme and Pen Recycling pilot

Slides and recording of Diabetes UK 2024 - in collaboration with Diabetes Specialist Nurse Forum UK

Sohail Akhtar - 29.03.24

Education17 Apr 2024

Diabetes UK 2024: Navigating Hyperglycaemia after GLP-1s with Insulin

Slides and recording of Diabetes UK 2024 - in collaboration with Diabetes Specialist Nurse Forum UK

Sohail Akhtar - 29.03.24

Education17 Apr 2024

Diabetes UK 2024: Connecting the Dots: Benefits of pen connectivity for people living with diabetes

Slides and recording of Diabetes UK 2024 - in collaboration with Diabetes Specialist Nurse Forum UK

Education23 Oct 2023

What Insulins Do I Need In My Toolbox To Support People With Type 2 Diabetes

Lantus® (insulin glargine 100 units/mL) Prescribing Information UK Toujeo® (insulin glargine 300 units/mL) Prescribing Information UK

Education23 Oct 2023

Diabetes UK 2023: Multifactorial approach to diabetes management

Education23 Oct 2023

Diabetes Podcast Series | Toujeo® (insulin glargine 300 Units/mL) | Lantus® (insulin glargine 100 units/mL)

Promotional podcasts on a variety of different topics and meetings that have been organised and funded by Sanofi

Prescribing Information Toujeo (insulin glargine 300 units/mL)Prescribing Information Lantus (insulin glargine 100 units/mL)

Education23 Oct 2023

Diabetes UK 2023: Cultural humility in diabetes consultation

MAT-XU-2305060 (v2.0) Date of preparation: December 2023

Therapeutic Areas
- Cardiology
  - Dyslipidaemia
  - Thrombosis
- Dermatology
  - Atopic Dermatitis
- Diabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
- Neurology
  - Multiple Sclerosis
- Oncology
  - Multiple Myeloma
  - Other Oncology Topics
- Rare Disease
- Respiratory
  - COPD
- Transplant
  - Transplant
- Vaccines
- Other Topics
  - General Topics
  - Payor
Articles
- Cardiology
  - Dyslipidaemia
  - Thrombosis
- Dermatology
  - Atopic Dermatitis
- Diabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
- Neurology
  - Multiple Sclerosis
- Oncology
  - Multiple Myeloma
  - Other Oncology Topics
- Rare Disease
- Respiratory
  - COPD
- Transplant
  - Transplant
- Vaccines
  - Influenza
- Other Topics
  - General Topics
Resources
- Cardiology
  - Dyslipidaemia
- Dermatology
  - Atopic Dermatitis
- Diabetes
  - Type 1 Diabetes
- Oncology
  - Multiple Myeloma
- Rare Disease
- Vaccines
- Other Topics
  - Payor
Tools
- Dermatology
  - Atopic Dermatitis
Events
- Diabetes
  - Type 2 Diabetes
Education
- Cardiology
  - Dyslipidaemia
- Diabetes
  - Type 1 Diabetes
  - Type 2 Diabetes
- Transplant
  - Transplant
- Vaccines
  - Other Vaccines Topics
Products